These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1324 related articles for article (PubMed ID: 21057493)

  • 41. Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression.
    Cimmino L; Dolgalev I; Wang Y; Yoshimi A; Martin GH; Wang J; Ng V; Xia B; Witkowski MT; Mitchell-Flack M; Grillo I; Bakogianni S; Ndiaye-Lobry D; Martín MT; Guillamot M; Banh RS; Xu M; Figueroa ME; Dickins RA; Abdel-Wahab O; Park CY; Tsirigos A; Neel BG; Aifantis I
    Cell; 2017 Sep; 170(6):1079-1095.e20. PubMed ID: 28823558
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX.
    Ko M; An J; Bandukwala HS; Chavez L; Aijö T; Pastor WA; Segal MF; Li H; Koh KP; Lähdesmäki H; Hogan PG; Aravind L; Rao A
    Nature; 2013 May; 497(7447):122-6. PubMed ID: 23563267
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FISH analysis for TET2 deletion in a cohort of 362 Brazilian myeloid malignancies: correlation with karyotype abnormalities.
    de Oliveira FM; Miguel CE; Lucena-Araujo AR; de Lima AS; Falcão RP; Rego EM
    Med Oncol; 2013 Mar; 30(1):483. PubMed ID: 23389918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.
    Figueroa ME; Abdel-Wahab O; Lu C; Ward PS; Patel J; Shih A; Li Y; Bhagwat N; Vasanthakumar A; Fernandez HF; Tallman MS; Sun Z; Wolniak K; Peeters JK; Liu W; Choe SE; Fantin VR; Paietta E; Löwenberg B; Licht JD; Godley LA; Delwel R; Valk PJ; Thompson CB; Levine RL; Melnick A
    Cancer Cell; 2010 Dec; 18(6):553-67. PubMed ID: 21130701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss of 5-hydroxymethylcytosine in cancer: cause or consequence?
    Ficz G; Gribben JG
    Genomics; 2014 Nov; 104(5):352-7. PubMed ID: 25179374
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Flanking sequences influence the activity of TET1 and TET2 methylcytosine dioxygenases and affect genomic 5hmC patterns.
    Adam S; Bräcker J; Klingel V; Osteresch B; Radde NE; Brockmeyer J; Bashtrykov P; Jeltsch A
    Commun Biol; 2022 Jan; 5(1):92. PubMed ID: 35075236
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of combinatorial dysfunctions of Tet2 and Ezh2 on the epigenome in the pathogenesis of myelodysplastic syndrome.
    Hasegawa N; Oshima M; Sashida G; Matsui H; Koide S; Saraya A; Wang C; Muto T; Takane K; Kaneda A; Shimoda K; Nakaseko C; Yokote K; Iwama A
    Leukemia; 2017 Apr; 31(4):861-871. PubMed ID: 27694924
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clonal leukemic evolution in myelodysplastic syndromes with TET2 and IDH1/2 mutations.
    Lin TL; Nagata Y; Kao HW; Sanada M; Okuno Y; Huang CF; Liang DC; Kuo MC; Lai CL; Lee EH; Shih YS; Tanaka H; Shiraishi Y; Chiba K; Lin TH; Wu JH; Miyano S; Ogawa S; Shih LY
    Haematologica; 2014 Jan; 99(1):28-36. PubMed ID: 23996483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia.
    Ponciano-Gómez A; Martínez-Tovar A; Vela-Ojeda J; Olarte-Carrillo I; Centeno-Cruz F; Garrido E
    Tumour Biol; 2017 Oct; 39(10):1010428317732181. PubMed ID: 28992762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TET2 expression level and 5-hydroxymethylcytosine are decreased in refractory cytopenia of childhood.
    Coutinho DF; Monte-Mór BC; Vianna DT; Rouxinol ST; Batalha AB; Bueno AP; Boulhosa AM; Fernandez TS; Pombo-de-Oliveira MS; Gutiyama LM; Abdelhay E; Zalcberg IR
    Leuk Res; 2015 Oct; 39(10):1103-8. PubMed ID: 26277372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early Expression of Tet1 and Tet2 in Mouse Zygotes Altered DNA Methylation Status and Affected Embryonic Development.
    Qi Q; Wang Q; Liu K; Bian J; Yu Z; Hou J
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955629
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Invariant phenotype and molecular association of biallelic
    Awada H; Nagata Y; Goyal A; Asad MF; Patel B; Hirsch CM; Kuzmanovic T; Guan Y; Przychodzen BP; Aly M; Adema V; Shen W; Williams L; Nazha A; Abazeed ME; Sekeres MA; Radivoyevitch T; Haferlach T; Jha BK; Visconte V; Maciejewski JP
    Blood Adv; 2019 Feb; 3(3):339-349. PubMed ID: 30709865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genome-wide characterization of dynamic DNA 5-hydroxymethylcytosine and TET2-related DNA demethylation during breast tumorigenesis.
    Wu SL; Yang L; Huang C; Li Q; Ma C; Yuan F; Zhou Y; Wang X; Tong WM; Niu Y; Jin F
    Clin Epigenetics; 2024 Sep; 16(1):125. PubMed ID: 39261937
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 5-hydroxymethylcytosine marks regions with reduced mutation frequency in human DNA.
    Tomkova M; McClellan M; Kriaucionis S; Schuster-Boeckler B
    Elife; 2016 May; 5():. PubMed ID: 27183007
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human blood cell levels of 5-hydroxymethylcytosine (5hmC) decline with age, partly related to acquired mutations in TET2.
    Buscarlet M; Tessier A; Provost S; Mollica L; Busque L
    Exp Hematol; 2016 Nov; 44(11):1072-1084. PubMed ID: 27475703
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distinct roles of the methylcytosine oxidases Tet1 and Tet2 in mouse embryonic stem cells.
    Huang Y; Chavez L; Chang X; Wang X; Pastor WA; Kang J; Zepeda-Martínez JA; Pape UJ; Jacobsen SE; Peters B; Rao A
    Proc Natl Acad Sci U S A; 2014 Jan; 111(4):1361-6. PubMed ID: 24474761
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Non-catalytic Roles of Tet2 Are Essential to Regulate Hematopoietic Stem and Progenitor Cell Homeostasis.
    Ito K; Lee J; Chrysanthou S; Zhao Y; Josephs K; Sato H; Teruya-Feldstein J; Zheng D; Dawlaty MM; Ito K
    Cell Rep; 2019 Sep; 28(10):2480-2490.e4. PubMed ID: 31484061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of high 5-hydroxymethylcytosine levels with Ten Eleven Translocation 2 overexpression and inflammation in Sjögren's syndrome patients.
    Lagos C; Carvajal P; Castro I; Jara D; González S; Aguilera S; Barrera MJ; Quest AFG; Bahamondes V; Molina C; Urzúa U; Hermoso MA; Leyton C; González MJ
    Clin Immunol; 2018 Nov; 196():85-96. PubMed ID: 29894742
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Down-regulation of TET2 in CD3⁺ and CD34⁺ cells of myelodysplastic syndromes and enhances CD34⁺ cells proliferation.
    Zhang W; Shao Z; Fu R; Wang H; Li L; Liu H
    Int J Clin Exp Pathol; 2015; 8(9):10840-6. PubMed ID: 26617797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 67.